Clinical Trial

EHA2023 | Crovalimab Appears Non-inferior to Eculizumab in PNH, Data Shows

At the 2023 EHA Congress, researchers presented data from the ongoing COMMODORE 2 study, which was designed to determine whether crovalimab is non-inferior to eculizumab for multiple clinical endpoints among…